The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N2-[2-(1,1-Dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methylquinolin-4-yl]glycinamide ID: ALA4163590
PubChem CID: 145957542
Max Phase: Preclinical
Molecular Formula: C22H23FN4O
Molecular Weight: 378.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2nc(N3CCCc4ccc(F)cc4C3)cc(NCC(N)=O)c2c1
Standard InChI: InChI=1S/C22H23FN4O/c1-14-4-7-19-18(9-14)20(25-12-21(24)28)11-22(26-19)27-8-2-3-15-5-6-17(23)10-16(15)13-27/h4-7,9-11H,2-3,8,12-13H2,1H3,(H2,24,28)(H,25,26)
Standard InChI Key: HJKRULSUYDXCCS-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
5.4807 -11.6250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1903 -11.2155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1875 -10.3929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4789 -9.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7726 -11.2160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7749 -10.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0690 -9.9892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3603 -10.3967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3620 -11.2176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0685 -11.6230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8987 -11.6230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4754 -9.1704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1814 -8.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8908 -9.1643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5968 -8.7527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5666 -11.1629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8357 -12.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4379 -12.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2461 -12.8655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3474 -11.4003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6540 -12.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4623 -12.2711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9649 -11.6260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6534 -10.8663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8460 -10.7575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6525 -9.9883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1531 -10.2196 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.8943 -9.9815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
2 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
11 16 1 0
16 20 1 0
11 17 1 0
17 18 1 0
21 19 1 0
18 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
8 26 1 0
24 27 1 0
14 28 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.45Molecular Weight (Monoisotopic): 378.1856AlogP: 3.53#Rotatable Bonds: 4Polar Surface Area: 71.25Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.25CX LogP: 3.84CX LogD: 2.29Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.73Np Likeness Score: -1.71
References 1. Zheng X, Liang C, Wang L, Wang B, Liu Y, Feng S, Wu JZ, Gao L, Feng L, Chen L, Guo T, Shen HC, Yun H.. (2018) Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors., 61 (22): [PMID:30339388 ] [10.1021/acs.jmedchem.8b01394 ]